Last reviewed · How we verify
IPV control vaccine
IPV (inactivated poliovirus vaccine) stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3, preventing poliomyelitis infection.
IPV (inactivated poliovirus vaccine) stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3, preventing poliomyelitis infection. Used for Poliomyelitis prevention in infants and children, Poliomyelitis prevention in adults (booster or primary series).
At a glance
| Generic name | IPV control vaccine |
|---|---|
| Sponsor | Sinovac Biotech Co., Ltd |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
The vaccine contains chemically inactivated poliovirus particles that trigger both humoral (antibody) and cellular immune responses without causing disease. This immunization provides protection against all three serotypes of poliovirus, preventing the virus from infecting motor neurons and causing paralysis. The inactivated formulation offers a safe alternative to live attenuated vaccines.
Approved indications
- Poliomyelitis prevention in infants and children
- Poliomyelitis prevention in adults (booster or primary series)
Common side effects
- Injection site pain, redness, or swelling
- Fever
- Irritability or fussiness
- Myalgia
Key clinical trials
- Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine (PHASE4)
- Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age (PHASE3)
- Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh (PHASE2)
- Confirmatory Study of BK1310 in Healthy Infants (PHASE3)
- Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell) (PHASE3)
- A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine (PHASE3)
- A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IPV control vaccine CI brief — competitive landscape report
- IPV control vaccine updates RSS · CI watch RSS
- Sinovac Biotech Co., Ltd portfolio CI